Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CLEVECORD safely and effectively. See full prescribing information for CLEVECORD.CLEVECORD (HPC, Cord Blood)Injectable Suspension for Intravenous UseInitial U.S. Approval: 1 September 2016
Medication labelWhy this: Advisory · dailymed-other
CLEVECORD, HPC (Hematopoietic Progenitor Cell), Cord Blood, is an allogeneic cord blood hematopoietic progenitor cell therapy indicated for use in unrelated donor hematopoietic progenitor stem cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment. The risk benefit assessment for an individual patient depends on the patient characteristics, including disease, stage, risk factors, and specific manifestations of the disease, on characteristics of the graft, and on other available treatments or types of hematopoietic progenitor cells.
- generic_name
- hpc (hematopoietic progenitor cell), cord blood
- product_names
- HPC (Hematopoietic Progenitor Cell), Cord Blood
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en